SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
Jenny
Lv2
150 积分
2024-04-07 加入
最近求助
最近应助
互助留言
An Innovative Approach to Optimize First‐In‐Human Minimal Anticipated Biological Effect Level Based Starting Dose in Oncology Trials for Bispecific T‐Cell Engagers: Experience from A Solid Tumor Bispecific T‐Cell Engager
7天前
已完结
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
27天前
已完结
[Consensus on clinical diagnosis and treatment of fumarate hydratase-deficient renal cell carcinoma]
29天前
已完结
Characterization of FH-deficient renal cell carcinoma
29天前
已完结
Efficacy and safety of KRAS G12C inhibitor IBI351 monotherapy in patients with advanced non-small cell lung cancer: results from a phase 2 pivotal study
1个月前
已完结
Pembrolizumab for previously treated, microsatellite instability–high/mismatch repair–deficient advanced colorectal cancer: final analysis of KEYNOTE-164
2个月前
已完结
宫颈癌组织中TRIM59、CCNE1的表达及其与预后的关系
2个月前
已完结
CCNE1Amplification as a Therapeutic Target
2个月前
已完结
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
2个月前
已完结
Spotlight on the treatment of non‐small cell lung cancer with rare genetic alterations and brain metastasis: Current status and future perspectives
3个月前
已完结
没有进行任何应助
速度真快,,帮大忙了,谢谢!
7天前
帮大忙了
27天前
非常感谢
29天前
速度真快,,帮大忙了,谢谢!
29天前
太感谢了,非常及时。谢谢!
1个月前
速度真快,太感谢了。
2个月前
速度真快,帮大忙了
2个月前
速度真快,,感谢
2个月前
Thank you so much!
2个月前
Thank you.
3个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论